go-v.orgcodex
Menu
Page tools

codex · Chemistry

Prusogliptin

Diagram for Prusogliptin
Prusogliptin (DBPR108) is an experimental DPP-4 inhibitor developed by CSPC Pharmaceutical Group to treat type 2 diabetes. · image: Wikimedia Commons

Prusogliptin (DBPR108) is an experimental DPP-4 inhibitor developed by CSPC Pharmaceutical Group to treat type 2 diabetes.

Wikipedia contributors, "Prusogliptin", Wikipedia, revision 1330457733, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex